GlassScriptPhysician profile
Telisha Mooney Nemec
NPI 1306565577
$3,351.58
in general payments reported to CMS, 2019-2025
10 companies · $762 in 2025
The $762 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $998 · 2023: $1,164 · 2024: $428 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,354.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,211.57 | 2022-2025 | |
| Madrigal Pharmaceuticals | $367.35 | 2024-2025 | Rezdiffra, Resmetirom |
| Regeneron Healthcare Solutions, INC. | $213.90 | 2022-2024 | Dupixent |
| Intercept Pharmaceuticals, INC. | $193.29 | 2022-2023 | Ocaliva |
| Genzyme Corporation | $153.34 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $100.73 | 2022-2025 | Gattex, Eohilia |
| Gilead Sciences, INC. | $37.41 | 2023 | |
| Evoke Pharma, INC. | $32.19 | 2022-2023 | Gimoti |
| Ardelyx, INC. | $28.38 | 2023 | Ibsrela |
| Celgene Corporation | $13.42 | 2023 | Zeposia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Telisha Nemec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.